<?xml version="1.0"?>
<Articles JournalTitle="International Journal of Hematology-Oncology and Stem Cell Research">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>International Journal of Hematology-Oncology and Stem Cell Research</JournalTitle>
      <Issn>2008-2207</Issn>
      <Volume>9</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2015</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Involvement of MicroRNA in T-Cell Differentiation and Malignancy</title>
    <FirstPage>33</FirstPage>
    <LastPage>49</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Najmaldin</FirstName>
        <LastName>Saki</LastName>
        <affiliation locale="en_US">Department of Hematology and Blood Banking, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Saeid</FirstName>
        <LastName>Abroun</LastName>
        <affiliation locale="en_US">Department of Hematology and Blood Banking, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Soleimani</LastName>
        <affiliation locale="en_US">Department of Hematology and Blood Banking, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Saeideh</FirstName>
        <LastName>Hajizamani</LastName>
        <affiliation locale="en_US">Health research institute, Research Center of Thalassemia &amp; Hemoglobinopathy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Shahjahani</LastName>
        <affiliation locale="en_US">Department of Hematology and Blood Banking, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Richard E</FirstName>
        <LastName>Kast</LastName>
        <affiliation locale="en_US">IIAIGC Headquarters, Dean of Studies, Burlington, VT, USA.</affiliation>
      </Author>
      <Author>
        <FirstName>Yousef</FirstName>
        <LastName>Mortazavi</LastName>
        <affiliation locale="en_US">Department of Pathology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">MicroRNAs are 19-22 nucleotide RNAs involved in such important processes as development, proliferation, differentiation and apoptosis. Different miRNAs are uniquely expressed in lymphoid T cells, and play a role indevelopment and differentiation of various subtypes by targeting their target genes. Recent studies have shown that aberrant miRNA expression may be involved in T cell leukemogenesis and lymphogenesis, and may function as tumor suppressor (such as miR-451, miR-31, miR-150, and miR-29a) or oncogene (e.g. miR-222, miR-223, miR-17-92, miR-155). MiRNAs can be used as new biomarkers for prognosis and diagnosis or as an index of disease severity in T-cell leukemia and lymphoma. This article presents a review of studies in recent years on the role of miRNAs in T-cell development and their aberrant expression in pathogenesis of T-cell leukemia and lymphoma. Characterizing miRNAs can help recognize their role as new important molecules with prognostic and therapeutic applications.</abstract>
    <web_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/396</web_url>
    <pdf_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/download/396/401</pdf_url>
  </Article>
</Articles>
